Page last updated: 2024-08-18

1-naphthylamine and Granulocytic Leukemia, Chronic

1-naphthylamine has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, L; Du, X; Jin, B; Jin, Y; Li, J; Li, P; Pan, J; Ren, R; Wang, Y; Xu, F; Zhou, J1

Other Studies

1 other study(ies) available for 1-naphthylamine and Granulocytic Leukemia, Chronic

ArticleYear
Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.
    The Journal of clinical investigation, 2016, 10-03, Volume: 126, Issue:10

    Topics: 1-Naphthylamine; Aminoquinolines; Animals; Antineoplastic Agents; Carbazoles; Cell Line, Tumor; Cell Proliferation; Cell Survival; Enzyme Induction; Female; Fusion Proteins, bcr-abl; Gene Expression; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HEK293 Cells; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Molecular Targeted Therapy; Neoplastic Stem Cells; Protein-Arginine N-Methyltransferases; Pyrimidines; RNA, Small Interfering; STAT5 Transcription Factor; Xenograft Model Antitumor Assays

2016